306 related articles for article (PubMed ID: 24279471)
1. Prognostic value of a nine-gene signature in glioma patients based on mRNA expression profiling.
Bao ZS; Li MY; Wang JY; Zhang CB; Wang HJ; Yan W; Liu YW; Zhang W; Chen L; Jiang T
CNS Neurosci Ther; 2014 Feb; 20(2):112-8. PubMed ID: 24279471
[TBL] [Abstract][Full Text] [Related]
2. Rab27a was identified as a prognostic biomaker by mRNA profiling, correlated with malignant progression and subtype preference in gliomas.
Wang H; Zhao Y; Zhang C; Li M; Jiang C; Li Y
PLoS One; 2014; 9(2):e89782. PubMed ID: 24587032
[TBL] [Abstract][Full Text] [Related]
3. RAB38 confers a poor prognosis, associated with malignant progression and subtype preference in glioma.
Wang H; Jiang C
Oncol Rep; 2013 Nov; 30(5):2350-6. PubMed ID: 24026199
[TBL] [Abstract][Full Text] [Related]
4. BMP4, a strong better prognosis predictor, has a subtype preference and cell development association in gliomas.
Bao Z; Zhang C; Yan W; Liu Y; Li M; Zhang W; Jiang T
J Transl Med; 2013 Apr; 11():100. PubMed ID: 23590708
[TBL] [Abstract][Full Text] [Related]
5. Identification of high risk anaplastic gliomas by a diagnostic and prognostic signature derived from mRNA expression profiling.
Zhang CB; Zhu P; Yang P; Cai JQ; Wang ZL; Li QB; Bao ZS; Zhang W; Jiang T
Oncotarget; 2015 Nov; 6(34):36643-51. PubMed ID: 26436699
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of a microRNA signature as a novel biomarker in patients with lower-grade gliomas.
Qian Z; Li Y; Fan X; Zhang C; Wang Y; Jiang T; Liu X
J Neurooncol; 2018 Mar; 137(1):127-137. PubMed ID: 29204839
[TBL] [Abstract][Full Text] [Related]
7. Identification and validation of a novel eight mutant-derived long non-coding RNAs signature as a prognostic biomarker for genome instability in low-grade glioma.
Maimaiti A; Wang X; Pei Y; Nuermaimaiti N; Tuersunniyazi A; Abula Y; Feng Z; Jiang L; Shi X; Kasimu M
Aging (Albany NY); 2021 Jun; 13(11):15164-15192. PubMed ID: 34081618
[TBL] [Abstract][Full Text] [Related]
8. RNA processing genes characterize RNA splicing and further stratify lower-grade glioma.
Chai RC; Li YM; Zhang KN; Chang YZ; Liu YQ; Zhao Z; Wang ZL; Chang YH; Li GZ; Wang KY; Wu F; Wang YZ
JCI Insight; 2019 Aug; 5(17):. PubMed ID: 31408440
[TBL] [Abstract][Full Text] [Related]
9. Identification and validation of a 21-mRNA prognostic signature in diffuse lower-grade gliomas.
Song LR; Weng JC; Huo XL; Wang L; Li H; Li D; Wu Z; Zhang JT
J Neurooncol; 2020 Jan; 146(1):207-217. PubMed ID: 31853837
[TBL] [Abstract][Full Text] [Related]
10. CKS2 (CDC28 protein kinase regulatory subunit 2) is a prognostic biomarker in lower grade glioma: a study based on bioinformatic analysis and immunohistochemistry.
Hu M; Li Z; Qiu J; Zhang R; Feng J; Hu G; Ren J
Bioengineered; 2021 Dec; 12(1):5996-6009. PubMed ID: 34494924
[TBL] [Abstract][Full Text] [Related]
11. Identification and validation of a risk signature based on extracellular matrix-related genes in gliomas.
Liu J; Li G
Medicine (Baltimore); 2021 Apr; 100(16):e25603. PubMed ID: 33879726
[TBL] [Abstract][Full Text] [Related]
12. An Immune-Related lncRNA Signature to Predict Survival In Glioma Patients.
Xia P; Li Q; Wu G; Huang Y
Cell Mol Neurobiol; 2021 Mar; 41(2):365-375. PubMed ID: 32410107
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of ion channel genes in Chinese patients with gliomas based on mRNA expression profiling.
Lu FF; Wang HY; He XZ; Liang TY; Wang W; Hu HM; Wu F; Liu YW; Zhang SZ
J Neurooncol; 2017 Sep; 134(2):397-405. PubMed ID: 28752501
[TBL] [Abstract][Full Text] [Related]
14. Bioinformatic Profiling Identifies a Glucose-Related Risk Signature for the Malignancy of Glioma and the Survival of Patients.
Zhao S; Cai J; Li J; Bao G; Li D; Li Y; Zhai X; Jiang C; Fan L
Mol Neurobiol; 2017 Dec; 54(10):8203-8210. PubMed ID: 27900679
[TBL] [Abstract][Full Text] [Related]
15. An immune-related lncRNA signature for patients with anaplastic gliomas.
Wang W; Zhao Z; Yang F; Wang H; Wu F; Liang T; Yan X; Li J; Lan Q; Wang J; Zhao J
J Neurooncol; 2018 Jan; 136(2):263-271. PubMed ID: 29170907
[TBL] [Abstract][Full Text] [Related]
16. Identification and Validation of an Energy Metabolism-Related lncRNA-mRNA Signature for Lower-Grade Glioma.
Zhao J; Wang L; Wei B
Biomed Res Int; 2020; 2020():3708231. PubMed ID: 32802843
[TBL] [Abstract][Full Text] [Related]
17. Cell aging related genes can be used to characterize clinical prognoses and further stratify diffuse gliomas.
Yang Y; Chen X; Sun J; Chen S; Yang C; Ma Q; Yang J
Sci Rep; 2021 Sep; 11(1):19493. PubMed ID: 34593910
[TBL] [Abstract][Full Text] [Related]
18. Classifying lower grade glioma cases according to whole genome gene expression.
Chen B; Liang T; Yang P; Wang H; Liu Y; Yang F; You G
Oncotarget; 2016 Nov; 7(45):74031-74042. PubMed ID: 27677590
[TBL] [Abstract][Full Text] [Related]
19. A five-microRNA signature for individualized prognosis evaluation and radiotherapy guidance in patients with diffuse lower-grade glioma.
Zhang JH; Hou R; Pan Y; Gao Y; Yang Y; Tian W; Zhu YB
J Cell Mol Med; 2020 Jul; 24(13):7504-7514. PubMed ID: 32412186
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive profiling identifies a novel signature with robust predictive value and reveals the potential drug resistance mechanism in glioma.
Zeng F; Wang K; Liu X; Zhao Z
Cell Commun Signal; 2020 Jan; 18(1):2. PubMed ID: 31907037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
